This new platform bridges the gap between routine patient care and clinical research, creating a single, comprehensive wound ...

The site management organization (SMO) market is set for robust growth, driven by rising clinical trial complexity and volume. Key opportunities lie in the increasing need for patient recruitment, ...

Worldwide becomes first CRO to implement Medidata Plus, gaining access to enterprise-level AI across the Medidata Study, Data, and Patient ExperiencesResearch Triangle Park, NC and New York – April 23 ...

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $74 billion of capital under management, is ...

Paragonix Technologies, Inc., a pioneer in organ transplant technologies, organ offer, and surgical recovery services, today announced the presentation of new clinical research at the 2026 ...

Advances in AI, automation, wearable technology, and gene therapies are converging to transform clinical research practices. Developments range from Ocugen’s concentrated retinal gene therapy trial ...

Paradigm Health today announced SPIRE -- Scalable Platform for Integrated Research & Evidence -- a new model for post-approval and late-stage clinical studies designed to help sponsors generate ...

The early recognition of type 1 diabetes in a toddler with increased thirst, lethargy, vision difficulties, and fruity breath ...

Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced it has entered into ...

Celerion, a global leader in clinical pharmacology and bioanalytical sciences, today announced a majority investment from THL ...

At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Interpersonal Project Management Skills for the Life Sciences Industries (July 16th - July 17th, 2026)" has been added ...